Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/11/2025 ,inter alia, to consider and approve Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has called a Board meeting on 28 November 2025 at 5:00 PM at its Chennai corporate office. Key items on the agenda include recommending the appointment of two new Directors — Ms. Ritu Tiwari and Ms. Nikita Sinha. The Board will also consider signing an agreement with MR FRANCHISE to appoint around 200 channel partners across India for business expansion. Additionally, the meeting will approve a scrutinizer for the upcoming Extra-Ordinary General Meeting (EGM) and finalize the EGM's date, time, and venue. The intimation was signed by Managing Director Nanjappan Aravind.
The proposed appointment of two directors and a large-scale channel partner expansion plan suggest the company is preparing for a growth phase, but no financial figures or business impact details have been disclosed yet. Shareholders should watch the EGM outcome for further clarity.